16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Assessing the role of patient support services on adherence rates in patients using glatiramer acetate for relapsing-remitting multiple sclerosis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To assess predictors of achievement of 80% Medication Possession Ratio (MPR) in patients receiving manufacturer-provided self-management services for relapsing-remitting multiple sclerosis (RRMS) patients taking glatiramer acetate (Copaxone).

          Related collections

          Author and article information

          Journal
          J Med Econ
          Journal of medical economics
          Informa Healthcare
          1941-837X
          1369-6998
          2013
          : 16
          : 2
          Affiliations
          [1 ] Teva Neuroscience, 901 W. 104th St, Kansas City, MO 64131, USA.
          Article
          10.3111/13696998.2012.744316
          23098539
          f6a6e2e8-7d71-442b-8c79-76497cf64212
          History

          Comments

          Comment on this article